Business Context and Reporting Period
Company: American Shared Hospital Services (ASHS)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2007
Business Overview: ASHS provides Gamma Knife stereotactic radiosurgery equipment and services to medical centers, primarily through its 81% interest in GK Financing, LLC (GKF). As of March 2008, the company operated 19 Gamma Knife units in 17 states. Gamma Knife revenue accounted for 97% of total revenue in 2007. The company also operates one Image Guided Radiation Therapy (IGRT) site and is developing a Proton Beam Radiation Therapy (PBRT) business through investments in Still River Systems, Inc.
Key Financial Metrics (Year Ended Dec 31, 2007)
| Metric | 2007 | 2006 |
|---|---|---|
| Total Revenue | $22,622,000 | $20,385,000 |
| Net Income | $951,000 | $1,656,000 |
| Earnings Per Share (Diluted) | $0.19 | $0.33 |
| Operating Cash Flow | $8,484,000 | $9,164,000 |
| Cash and Cash Equivalents | $6,340,000 | $3,952,000 |
| Working Capital | $747,000 | ($541,000) Deficit |
| Total Debt & Capital Leases | $32,276,000 | $21,065,000 |
| Line of Credit Utilized | $4,100,000 | $4,000,000 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 11.0% to $22.6 million. This was driven primarily by a one-time $3.2 million equipment sale of a Perfexion Gamma Knife unit to an existing customer. Excluding this sale, medical services revenue decreased 7.5% due to the termination of one Gamma Knife contract and a decline in procedure volume at existing sites.
- Profitability Decline: Net income fell 42.6% to $951,000. This decrease was attributed to lower medical services revenue, a loss on the disposal of assets ($186,000), and increased selling and administrative expenses ($651,000 increase) related to business development for the PBRT initiative.
- Debt Expansion: Long-term debt and capital leases increased significantly to $32.3 million from $21.1 million in 2006, reflecting financing for new equipment (Perfexion units, IGRT system) and progress payments for future PBRT systems.
- Liquidity Improvement: Cash and cash equivalents rose to $6.3 million, aided by the conversion of marketable securities to cash and strong operating cash flows, turning a working capital deficit in 2006 into a positive position in 2007.
Guidance, Outlook, Risks, and Unusual Items
- Dividend Suspension: The Board of Directors suspended quarterly dividends after July 2007 to preserve cash for the development of the PBRT business.
- Strategic Investments: The company has committed approximately $30 million to purchase three Gamma Knife units and two Monarch 250 PBRT systems. As of year-end, deposits totaled approximately $8.2 million. The PBRT systems are not yet FDA approved, with anticipated delivery in 2009.
- Reimbursement Risks: Revenue is sensitive to Medicare and third-party payer reimbursement rates. The 2008 outpatient payment rate for Gamma Knife procedures was reduced by approximately 5% compared to 2007. Additionally, IGRT reimbursement rates were packaged into other codes in 2008, eliminating specific outpatient rates.
- Contract Termination: One existing Gamma Knife customer exercised an early termination provision effective March 25, 2008. A new contract with USC University Hospital was signed in March 2008, expected to be operational in late 2008.
- Market Risk: The company faces competition from conventional neurosurgery, other radiosurgery devices, and direct equipment purchases by hospitals. The market for Gamma Knife units is considered mature.
Investor Verification Checklist
- Equipment Sale Sustainability: Verify the extent to which the 2007 revenue growth was driven by the non-recurring $3.2 million equipment sale versus organic medical services growth.
- PBRT Viability: Assess the risk associated with the $30 million commitment to Still River Systems, specifically the timeline for FDA approval and the potential for reimbursement rate reductions in 2008.
- Debt Service Capacity: Review the company's ability to service the increased debt load ($32.3 million) given the suspension of dividends and the reliance on operating cash flows.
- Customer Concentration: Confirm the impact of the March 2008 contract termination and the reliance on a single customer that accounted for 13% of revenue in 2007.
- Reimbursement Trends: Monitor the impact of the 5% reduction in 2008 Medicare outpatient rates and the packaging of IGRT codes on future revenue projections.